Meredith Hay

Dr. Meredith Hay is a Professor of Physiology at the University of Arizona College of Medicine and Founder and CEO of ProNeurogen, Inc.  Dr. Hay is Past-President of the American Physiological Society and the former Executive Vice President and Provost of The University of Arizona. Prior to Arizona, Dr. Hay served as Vice President for Research at the University of Iowa.   She is an international leader in understanding the effects of Angiotensin-(1-7)/Mas receptor pathways to inhibit brain inflammation, protect cognitive function, and prevent and treat Vascular Dementia and Alzheimer’s Disease Related Dementias.   ProNeurogen is an early clinical stage biopharmaceutical company developing novel peptide-based therapeutics to treat vascular dementia, chronic neuropathic pain (www.proneurogen.com).   Dr. Hay and ProNeurogen are collaborating with physicians and scientists across the country and  at the University of Arizona’s Sarver Heart Center, the Evelyn F. McKnight Brain Institute, Banner Alzheimer’s Institute and the National Institute on Aging to advance these peptides through clinical trials and FDA market approval.